Alpha Cognition (ACOG) Competitors

Alpha Cognition (NASDAQ:ACOG) and Benitec Biopharma (NASDAQ:BNTC) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

Is ACOG or BNTC more profitable?

Alpha Cognition's return on equity of 0.00% beat Benitec Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Cognition	N/A	N/A	-344.17%
Benitec Biopharma	N/A	-44.61%	-41.25%

Do analysts recommend ACOG or BNTC?

Alpha Cognition currently has a consensus target price of $20.00, indicating a potential upside of 385.44%. Benitec Biopharma has a consensus target price of $24.71, indicating a potential upside of 79.74%. Given Alpha Cognition's higher possible upside, analysts clearly believe Alpha Cognition is more favorable than Benitec Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Benitec Biopharma	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	3.22

Do institutionals and insiders believe in ACOG or BNTC?

52.2% of Benitec Biopharma shares are held by institutional investors. 31.5% of Alpha Cognition shares are held by insiders. Comparatively, 1.3% of Benitec Biopharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the media favor ACOG or BNTC?

In the previous week, Benitec Biopharma had 4 more articles in the media than Alpha Cognition. MarketBeat recorded 5 mentions for Benitec Biopharma and 1 mentions for Alpha Cognition. Benitec Biopharma's average media sentiment score of 0.59 beat Alpha Cognition's score of -0.24 indicating that Benitec Biopharma is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Cognition	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Benitec Biopharma	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable earnings and valuation, ACOG or BNTC?

Alpha Cognition has higher earnings, but lower revenue than Benitec Biopharma. Benitec Biopharma is trading at a lower price-to-earnings ratio than Alpha Cognition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Cognition	N/A	N/A	-$13.77M	-$1.82	-2.26
Benitec Biopharma	$80K	4,030.64	-$21.75M	-$1.51	-9.11

Which has more volatility & risk, ACOG or BNTC?

Alpha Cognition has a beta of 2.5, suggesting that its share price is 150% more volatile than the S&P 500. Comparatively, Benitec Biopharma has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500.

Does the MarketBeat Community favor ACOG or BNTC?

Benitec Biopharma received 195 more outperform votes than Alpha Cognition when rated by MarketBeat users. However, 66.67% of users gave Alpha Cognition an outperform vote while only 65.67% of users gave Benitec Biopharma an outperform vote.

Company	Underperform	Outperform
Alpha Cognition	Outperform Votes 2 66.67%	Underperform Votes 1 33.33%
Benitec Biopharma	Outperform Votes 197 65.67%	Underperform Votes 103 34.33%

Summary

Benitec Biopharma beats Alpha Cognition on 10 of the 17 factors compared between the two stocks.